Overview Request Sample Pages Request Customization Download PDF
You are viewing: South Korea Cell Culture Market analysis
Part of: Cell Culture Market (Global)

The South Korea Cell Culture Market was valued at $398 Million in 2026 and projected to reach to $738.9 Million by 2031, representing a compound annual growth rate of 13.2%. South Korea's cell culture market is positioned for exceptional growth through 2031, driven by the country's world-class research institutions, substantial government funding for life sciences, and growing pharmaceutical manufacturing capacity.

South Korea Cell Culture Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Cell Culture Market Trends and Insights

  • This 13.2% compound annual growth rate reflects South Korea's strengthening position as a biotechnology and pharmaceutical hub in Asia Pacific.
  • South Korea's advanced research infrastructure, government support for life sciences innovation, and growing biopharmaceutical manufacturing capabilities are driving demand for sophisticated cell culture technologies and media. The forecast period through 2031 demonstrates South Korea's commitment to expanding its cell culture capabilities across therapeutic development, vaccine production, and regenerative medicine applications.
  • South Korea's investment in contract research organizations (CROs) and contract manufacturing organizations (CMOs) is accelerating adoption of standardized cell culture systems.
  • South Korea's regulatory environment and skilled workforce position the country as a critical market for cell culture solutions in the Asia Pacific region..

Key Market Statistics

  • CAGR (2026-2031) 13.2% CAGR
  • Market Size, 2026 ~USD 398 Million
  • Forecast, 2031 ~USD 738.9 Million
  • Country South Korea

South Korea Cell Culture Market Overview

Strong CAGR Outpacing Global Average :

South Korea's cell culture market is growing at 13.2% CAGR (2026-2031), significantly exceeding the global rate of 12.1%, demonstrating the country's accelerating biotech momentum and market attractiveness.

Rapid Market Expansion :

The market is projected to nearly double from $398.0 million in 2026 to $738.9 million by 2031, reflecting South Korea's emergence as a critical Asia Pacific biotechnology and pharmaceutical manufacturing center.

Government-Backed Life Sciences Innovation :

South Korea's strategic government support for life sciences R&D, combined with advanced research infrastructure and favorable regulatory frameworks, is driving sustained investment in cell culture technologies and capabilities.

Asia Pacific Biotech Hub Status :

South Korea's strengthening position as a regional biotechnology leader attracts multinational pharmaceutical companies and biotech startups, creating robust demand for advanced cell culture solutions and services.

South Korea Cell Culture Market Dynamics

  • The nation's expertise in biopharmaceutical development and regenerative medicine research creates sustained demand for innovative cell culture technologies and services. Key growth catalysts include increasing investment in personalized medicine, expansion of contract manufacturing organizations (CMOs), and South Korea's strategic focus on becoming a global biotech innovation hub.
  • The market will benefit from rising collaborations between domestic biotech firms and international pharmaceutical companies, positioning South Korea as a critical supply chain partner for cell culture products and services in Asia Pacific..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • South Korea's cell culture market will nearly double from $398.0M (2026) to $738.9M (2031), driven by 13.2% CAGR growth.
    • South Korea's biopharmaceutical sector expansion and CRO/CMO investments are primary catalysts for cell culture technology adoption.
    • South Korea's advanced research infrastructure and government biotech initiatives support sustained market growth through 2031.
    • South Korea's position in Asia Pacific makes it a strategic hub for cell culture manufacturing and therapeutic development.

    Cell Culture Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment TISSUE ENGINEERING & REGENERATIVE MEDICINE (Application)
    Forecast Period 2026–2031
    Growth Rate CAGR of 12.1% from 2026 to 2031
    Largest Segment PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (End User)
    Market Size Base Year (Billions) ~USD 33 (2026)
    Revenue Forecast (Billions) ~USD 58.42 (2031)
    Segments Covered Product, Type, Application, End User

    South Korea Cell Culture Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Equipment

    By Type

    • Adult Bovine Sera
    • Antibiotics/Antimycotics
    • Attachment & Matrix Factors
    • Autoclaves
    • Balanced Salt Solutions
    • Bhk Media
    • Bioreactors
    • Biosafety Cabinets
    • Buffers & Chemicals
    • Carbon Dioxide Incubators
    • Cell & Gene Therapy
    • Cell Counters
    • Cell Dissociation Reagents
    • Cell Factory Systems/Cell Stacks
    • Centrifuges
    • Chemically-Defined Media
    • Cho Media
    • Classical Media & Salts
    • Contamination Detection Kits
    • Cryoprotective Reagents
    • Cryostorage Systems
    • Fetal Bovine Sera
    • Filtration Systems
    • Flasks
    • Growth Factors
    • Hek 293 Media
    • Media
    • Microscopes
    • Monoclonal Antibody Production
    • Multiwell Plates
    • Other Animal Sera
    • Other Consumables & Accessories
    • Other Media
    • Other Reagents
    • Other Serum-Free Media
    • Other Supporting Equipment
    • Other Therapeutic Protein Production
    • Other Tissue Engineering & Regenerative Medicine Applications
    • Petri Dishes
    • Reagents
    • Refrigerators & Freezers
    • Roller/Roux Bottles
    • Sera
    • Sera, Media, And Reagents
    • Serum-Free Media
    • Serum-Free Stem Cell Media
    • Specialty Media
    • Stem Cell Culture Media
    • Storage Equipment
    • Supplements
    • Supporting Equipment
    • Vaccine Production
    • Vero Cell Media
    • Vessels

    By Application

    • Biopharmaceutical Production
    • Diagnostics
    • Drug Screening & Development
    • Other Applications
    • Tissue Engineering & Regenerative Medicine

    By End User

    • Academic & Research Institutes
    • Hospitals & Diagnostic Laboratories
    • Other End Users
    • Pharmaceutical & Biotechnology Companies

    Target Audience

    • Pharmaceutical and Biotech Companies : South Korean and multinational pharma/biotech firms need market intelligence to guide R&D investments, manufacturing decisions, and product development strategies in the rapidly expanding cell culture sector.
    • Contract Manufacturing Organizations (CMOs) : CMOs operating in or targeting South Korea require detailed market data to assess capacity expansion opportunities, service offerings, and competitive positioning in the growing biopharmaceutical manufacturing landscape.
    • Cell Culture Technology Providers : Equipment, reagent, and media manufacturers need South Korea-specific market insights to identify customer segments, develop localized solutions, and establish distribution partnerships in this high-growth market.
    • Investment and Private Equity Firms : Investors evaluating biotech opportunities in South Korea require comprehensive market analysis to identify promising companies, assess growth potential, and make informed investment decisions in the cell culture sector.
    • Government and Policy Organizations : South Korean government agencies and policy makers need market data to evaluate life sciences initiatives, allocate R&D funding, and develop strategies to strengthen the country's biotech competitiveness.

    Key Companies in the South Korea Cell Culture Market

    CompanyHQOwnershipStrongest segments
    PATHEON INCNetherlandsPrivate CompanyDrug product services (oral, sterile, packaging, lifecycle management),Pharmaceutical development services (formulation, analytical, clinical supply),Drug substance services (small-molecule and biologics APIs),
    BIOMERIEUX S.A.FrancePublic CompanyClinical microbiology (culture media, VITEK, blood culture, ID/AST),Molecular and syndromic diagnostics (BIOFIRE, SPOTFIRE, ARGENE, NUCLISENS),Immunoassays and CLIA (VIDAS, Hybiome),
    SIGMA-ALDRICH CORPORATIONUnited StatesPrivate CompanyChemicals, biochemicals, and analytical reagents,Cell culture media, critical raw materials, and bioprocess solutions,Filtration, water purification, and labware,
    HI-MEDIAFrancePublic CompanyIn-content native and integrated formats,Geo-marketing and location-based solutions,Managed campaign and data-driven services,
    REPLIGEN CORPORATIONUnited StatesPublic CompanyFiltration and cell retention (XCell ATF, KrosFlo, TangenX, ProConnex TFDF),Chromatography (OPUS columns, KRM systems, resins, ELISA kits),Process analytics and PAT (PATsmart suite, SoloVPE/FlowVPE, ZipChip, REBEL),
    QIAGEN NVNetherlandsPublic CompanySample technology consumables and instruments,Immune response and infectious disease assays,Oncology and sexual & reproductive health assays,
    QUIDEL CORPORATIONUnited StatesPublic CompanyLabs (clinical chemistry and immunoassay),Transfusion Medicine,Point of Care,
    FLUOR CORPORATIONUnited StatesPublic CompanyEnergy Solutions,Urban Solutions,Mission Solutions,
    TECHNICOLOR SAFrancePublic CompanyBroadband gateways and routers (fiber, xDSL, cable),Wi-Fi extenders, Wi-Fi XL, homeware and in-home networking,Video set-top boxes, dongles, smart media devices,
    EIKEN CHEMICAL CO., LTD.JapanPublic CompanyFecal immunochemical test (FIT) reagents and analyzers,Microbiological reagents (clinical),Urinalysis test strips and analyzers,
    MAXCYTE, INCUnited StatesPublic CompanyExPERT Instruments (ATx, STx, GTx, VLx),Consumables (Processing Assemblies, Buffers, Accessories),Licensing and Technology Access,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences tools and genomic medicine,Diagnostics,
    MERCK KGAAGermanyPublic CompanyLife Science (tools, consumables, bioprocessing, CDMO),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials, equipment),
    SARTORIUS AGGermanyPublic CompanyBioprocess solutions (bioreactors, cell culture, fluid and process chromatography/filtration),Lab products and services (filtration, water systems, weighing, pipettes, microbiological testing),Analytical and PAT solutions (BLI, cytometry screening, live-cell imaging, SPR, data analytics),
    CORNING INCORPORATEDUnited StatesPublic CompanyOptical communications (fiber, cable, hardware, connectors),Display glass substrates (LCD/OLED),Specialty materials and optics,
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch panels, semiconductor and display materials, storage media, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, industrial inkjet),
    BDUnited StatesPublic CompanyMedical Essentials (syringes, needles, vascular access, sharps, enteral),Connected Care (infusion pumps, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery, related solutions),
    EPPENDORF SEGermanyPrivate CompanyLiquid handling (pipettes, dispensers, automated systems),Separation & instrumentation (centrifuges, PCR cyclers, ULT freezers),Consumables (tubes, tips, plates, single-use bioreactors),
    LONZASwitzerlandPublic CompanyIntegrated Biologics (mammalian DS/DP platforms),Advanced Synthesis (small molecules, HPAPIs, ADCs/bioconjugates),Specialized Modalities (cell & gene, microbial, bioscience, mRNA),
    GETINGESwedenPublic CompanyAcute Care Therapies (ECMO, ventilation, monitoring, ICU infrastructure, drainage),Surgical Workflows (OR equipment, anesthesia, OR integration, sterile supply management),Life Science (sterilization, biocontainment, bioprocess, labware cleaning, vivarium),
    AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab (Services, Consumables, Software),Applied Markets (GC, MS, Spectroscopy, Vacuum, Remarketed),
    BIO-TECHNEUnited StatesPublic CompanyProtein Sciences (reagents and proteomic tools),Diagnostics products and controls,Genomics and spatial biology,

    PATHEON INC

    Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and biotechnology services sector.

    BIOMERIEUX S.A.

    bioMérieux S.A. is a French public company founded in 1963 with 14,894 employees specializing in in vitro diagnostics and microbiology testing solutions.

    SIGMA-ALDRICH CORPORATION

    Sigma-Aldrich Corporation is a United States-based private company founded in 1951 with 9,800 employees, supplying research chemicals and biochemicals globally.

    HI-MEDIA

    HI-MEDIA is a French public company founded in 1996 with 29 employees that manufactures culture media and laboratory reagents for microbiology.

    REPLIGEN CORPORATION

    Repligen Corporation is a United States-based public company founded in 1981 with 2,000 employees providing bioprocessing solutions and chromatography products.

    QIAGEN NV

    QIAGEN NV is a Netherlands-based public company founded in 1984 with 5,500 employees specializing in molecular diagnostics and sample preparation technologies.

    QUIDEL CORPORATION

    Quidel Corporation is a United States-based public company founded in 1979 with 6,500 employees developing rapid diagnostic testing solutions.

    FLUOR CORPORATION

    Fluor Corporation is a United States-based public company founded in 1912 with 22,995 employees providing engineering, procurement, and construction services.

    TECHNICOLOR SA

    Technicolor SA is a France-based public company founded in 1985 with 1,552 employees offering media and entertainment technology services.

    EIKEN CHEMICAL CO., LTD.

    Eiken Chemical Co., Ltd. is a Japan-based public company founded in 1939 with 696 employees manufacturing diagnostic reagents and laboratory chemicals.

    MAXCYTE, INC

    MaxCyte, Inc. is a United States-based public company founded in 1998 with 91 employees developing cell engineering and electroporation technologies.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees providing laboratory equipment, reagents, and analytical instruments globally.

    DANAHER CORPORATION

    Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees operating diversified businesses in life sciences, diagnostics, and environmental solutions.

    MERCK KGAA

    Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees providing pharmaceuticals, chemicals, and life science products and services.

    SARTORIUS AG

    Sartorius AG is a Germany-based public company founded in 1870 with 14,242 employees manufacturing laboratory and bioprocess equipment for the life sciences industry.

    CORNING INCORPORATED

    Corning Incorporated is a United States-based public company founded in 1851 with 67,200 employees producing specialty glass, ceramics, and optical products.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japan-based public company founded in 1934 with 73,526 employees operating in imaging, information, and document solutions.

    BD

    BD is a United States-based public company founded in 1897 with 72,000 employees manufacturing medical devices, diagnostics, and life science tools.

    EPPENDORF SE

    Eppendorf SE is a Germany-based private company founded in 1945 with 4,358 employees manufacturing laboratory equipment and consumables for life sciences research.

    LONZA

    Lonza is a Switzerland-based public company founded in 1897 with 20,000 employees providing pharmaceutical and biotechnology manufacturing services and products.

    GETINGE

    Getinge is a Sweden-based public company founded in 1904 with 11,754 employees manufacturing medical devices and systems for healthcare and life sciences.

    AGILENT TECHNOLOGIES, INC.

    Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees providing analytical instruments and life sciences solutions.

    BIO-TECHNE

    Bio-Techne is a United States-based public company founded in 1976 with 3,100 employees providing protein reagents, antibodies, and analytical instruments for life sciences research.

    Reasons to Buy this Report

    • Identify High-Growth Market Opportunities : Gain detailed insights into South Korea's 13.2% CAGR cell culture market to identify investment opportunities and expansion strategies in one of Asia Pacific's fastest-growing biotech markets.
    • Competitive Intelligence for Market Entry : Understand South Korea's unique market dynamics, regulatory landscape, and competitive positioning to develop effective market entry strategies and partnership opportunities with local biotech and pharmaceutical players.
    • Strategic Supply Chain Planning : Leverage comprehensive market data to optimize supply chain decisions, identify key manufacturers and CMOs in South Korea, and capitalize on the country's growing role as a regional biotech manufacturing hub.
    • Technology and Innovation Benchmarking : Access detailed analysis of South Korea's advanced cell culture technologies, research capabilities, and innovation trends to benchmark your offerings and identify collaboration or acquisition targets.
    • Revenue Forecasting and Business Planning : Utilize precise market projections ($398M to $739M by 2031) for accurate financial modeling, revenue forecasting, and strategic business planning specific to the South Korean cell culture market.

    Frequently asked questions

    What is the projected size of South Korea's cell culture market by 2031?

    South Korea's cell culture market is forecast to reach $738.9 million by 2031, up from $398.0 million in 2026.

    What is the CAGR for South Korea's cell culture market?

    South Korea's cell culture market is expected to grow at a compound annual growth rate of 13.2% between 2026 and 2031.

    What factors are driving growth in South Korea's cell culture market?

    South Korea's growth is driven by expanding biopharmaceutical manufacturing, increased CRO/CMO investments, government biotech support, and rising demand for vaccine and therapeutic development.

    How does South Korea's cell culture market compare to the Asia Pacific region?

    South Korea represents a significant and fast-growing segment within Asia Pacific, leveraging advanced infrastructure and regulatory frameworks to support cell culture innovation and manufacturing.

    What applications are driving cell culture demand in South Korea?

    South Korea's cell culture demand is driven by biopharmaceutical development, vaccine production, regenerative medicine research, and contract manufacturing services for therapeutic applications.

    RESEARCH METHODOLOGY

    This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global cell culture market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell culture market. The secondary sources used for this study include World Health Organization (WHO), Food and Drug Administration, American Society for Cell Biology (ASCB), National Institutes of Health (NIH), International Society for Cell & Gene Therapy (ISCT), American Society for Gene and Cell Therapy (ASGCT), Centers of Disease Control and Prevention (CDC), International Serum Industry Association (ISIA), Pharmaceutical Research and Manufacturers of America (PhRMA), International Society for Vaccines (ISV), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the Society for In Vitro Biology (SIVB), Japan Agency for Medical Research and Development, European Federation of Pharmaceutical Industries and Associations (EFPIA), American Type Culture Collection (ATCC), and the Alliance for Regenerative Medicine (ARM); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

    Cell Culture Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell culture market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Cell Culture Market : Top-Down and Bottom-Up Approach

    Cell Culture Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Cell culture refers to the removal of cells from an animal or plant and their subsequent growth in an artificial environment under controlled conditions. It is a process of growing cells outside their natural environment, typically in a laboratory setting. This technique allows researchers to study cells in a controlled environment, providing insights into their behavior, growth, metabolism, and response to various stimuli.

    The scope of this report includes products such as equipment and consumables, such as media, sera, reagents, vessels, bioreactors, storage equipment, and other cell culture-supporting equipment that support the cell culture process.

    Key Stakeholders

    • Cell Culture Equipment and Reagents Manufacturers
    • Analytical and Life Science Instrumentation Companies
    • Academic and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Life Science Companies
    • Venture Capitalists and Investors
    • Government Organizations
    • Private Research Firms
    • Contract Research Organizations (CROs)
    • Hospitals and Diagnostic Laboratories
    • Cell Banks

    Report Objectives

    • To define, describe, and forecast the global cell culture market based on product, application, end user, and region
    • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall cell culture market
    • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
    • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the cell culture market
    • To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the cell culture market

    Available customizations:

    Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:

    Portfolio Analysis

    • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies.

    Regional Analysis

    • A further breakdown of the Rest of Europe cell culture market, by country
    • A further breakdown of the Rest of Asia Pacific cell culture market, by country
    • A further breakdown of the Rest of Latin America cell culture market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).

    Get the Full Cell Culture Market Report

    Full forecast, segment splits, and company analysis for all Cell Culture Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status